1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice. (2nd June 2016) Authors: Liu, Zhida; Zhou, Hang; Wang, Wenjun; Fu, Yang-Xin; Zhu, Mingzhao Journal: Oncoimmunology Issue: Volume 5:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice. (4th May 2018) Authors: Choi, Jae-Hyeog; Kim, Ki Hyang; Roh, Kug-Hwan; Jung, Hana; Lee, Anbok; Lee, Ji-Young; Song, Joo Yeon; Park, Seung Jae; Kim, Ilhwan; Lee, Won-Sik; Seo, Su-Kil; Choi, Il-Whan; Fu, Yang-Xin; Yea, Sung Su; Park, SaeGwang Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DNA sensing and immune responses in cancer therapy. (April 2017) Authors: Qiao, Jian; Tang, Haidong; Fu, Yang-Xin Journal: Current opinion in immunology Issue: Volume 45(2017) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Issue 1 (December 2017) Authors: Liang, Hua; Deng, Liufu; Hou, Yuzhu; Meng, Xiangjiao; Huang, Xiaona; Rao, Enyu; Zheng, Wenxin; Mauceri, Helena; Mack, Matthias; Xu, Meng; Fu, Yang-Xin; Weichselbaum, Ralph Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunotherapy and tumor microenvironment. Issue 1 (1st January 2016) Authors: Tang, Haidong; Qiao, Jian; Fu, Yang-Xin Journal: Cancer letters Issue: Volume 370:Issue 1(2016) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma. Issue 1 (19th March 2019) Authors: Espinosa-Cotton, Madelyn; Rodman III, Samuel N.; Ross, Kathleen A.; Jensen, Isaac J.; Sangodeyi-Miller, Kenley; McLaren, Ayana J.; Dahl, Rachel A.; Gibson-Corley, Katherine N.; Koch, Adam T.; Fu, Yang-Xin; Badovinac, Vladimir P.; Laux, Douglas; Narasimhan, Balaji; Simons, Andrean L. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. (25th October 2018) Authors: Deng, Mi; Gui, Xun; Kim, Jaehyup; Xie, Li; Chen, Weina; Li, Zunling; He, Licai; Chen, Yuanzhi; Chen, Heyu; Luo, Weiguang; Lu, Zhigang; Xie, Jingjing; Churchill, Hywyn; Xu, Yixiang; Zhou, Zhan; Wu, Guojin; Yu, Chenyi; John, Samuel; Hirayasu, Kouyuki; Nguyen, Nam Journal: Nature Issue: Volume 562:Number 7728(2018) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗